- Home
- ORLA vs ARWR Comparison
ORLA vs ARWR Comparison
Compare ORLA & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORLA
- ARWR
- Stock Information
- Founded
- ORLA 2007
- ARWR 2003
- Country
- ORLA Canada
- ARWR United States
- Employees
- ORLA N/A
- ARWR N/A
- Industry
- ORLA Precious Metals
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- ORLA Basic Materials
- ARWR Health Care
- Exchange
- ORLA Nasdaq
- ARWR Nasdaq
- Market Cap
- ORLA 2.3B
- ARWR 1.7B
- IPO Year
- ORLA N/A
- ARWR 1993
- Fundamental
- Price
- ORLA $9.34
- ARWR $12.74
- Analyst Decision
- ORLA Buy
- ARWR Buy
- Analyst Count
- ORLA 2
- ARWR 11
- Target Price
- ORLA $6.13
- ARWR $41.44
- AVG Volume (30 Days)
- ORLA 1.5M
- ARWR 1.6M
- Earning Date
- ORLA 03-18-2025
- ARWR 05-08-2025
- Dividend Yield
- ORLA N/A
- ARWR N/A
- EPS Growth
- ORLA N/A
- ARWR N/A
- EPS
- ORLA 0.27
- ARWR N/A
- Revenue
- ORLA $343,918,000.00
- ARWR $2,500,000.00
- Revenue This Year
- ORLA $138.03
- ARWR $4,380.43
- Revenue Next Year
- ORLA $5.24
- ARWR $58.72
- P/E Ratio
- ORLA $33.22
- ARWR N/A
- Revenue Growth
- ORLA 47.20
- ARWR N/A
- 52 Week Low
- ORLA $3.24
- ARWR $12.20
- 52 Week High
- ORLA $9.62
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- ORLA 68.03
- ARWR 27.27
- Support Level
- ORLA $9.05
- ARWR $14.69
- Resistance Level
- ORLA $9.56
- ARWR $15.65
- Average True Range (ATR)
- ORLA 0.49
- ARWR 0.78
- MACD
- ORLA 0.01
- ARWR -0.12
- Stochastic Oscillator
- ORLA 85.27
- ARWR 13.07
About ORLA Orla Mining Ltd.
Orla Mining Ltd is a mineral exploration company. It is engaged in the acquisition and exploration of mineral properties. The company holds three gold projects; the Camino Rojo gold and silver project in Zacatecas State, Mexico, and the South Railroad and Lewis gold projects in Nevada, USA, and the Cerro Quema gold project in Panama. It conducts business activities in Mexico, Panama, the United States, and Canada.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.